Apomorphine HCl Sterop 5 mg/ml inj./inf. sol. s.c. amp. 10 x 1 ml
Active ingredient: Apomorphine Hydrochloride
View notice details →
News topic
Current shortage notices for the ATC group ATC N04, structured by product, country and reporting period.
19 noticesThe 19 consolidated notices from Belgium, Czechia, Austria, Germany, Denmark are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.
Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.
Active ingredient: Apomorphine Hydrochloride
View notice details →Active ingredient: Pramipexole
View notice details →Active ingredient: Pramipexole
View notice details →Active ingredient: Pramipexole
View notice details →Active ingredient: LEVODOPA, INHIBITOR DEKARBOXYLASY A INHIBITOR COMT
View notice details →Active ingredient: Ropinirole
View notice details →Active ingredient: ROPINIROL HYDROCHLORID
View notice details →Active ingredient: PRAMIPEXOL
View notice details →Active ingredient: Apomorphine Hydrochloride
View notice details →Active ingredient: Safinamide
View notice details →Active ingredient: Cabergolin
View notice details →Active ingredient: Cabergolin
View notice details →Active ingredient: LEVODOPA A INHIBITOR DEKARBOXYLASY
View notice details →Active ingredient: PRAMIPEXOL
View notice details →Active ingredient: ROPINIROL HYDROCHLORID
View notice details →Active ingredient: PRAMIPEXOL DIHYDROCHLORID MONOHYDRAT
View notice details →Active ingredient: PRAMIPEXOL
View notice details →Active ingredient: Ropinirol (Ropinirolhydrochlorid)
View notice details →Active ingredient: Ropinirol (Ropinirolhydrochlorid)
View notice details →